Financial News
Latest News about NVO
Recent news which mentions NVO
From Benzinga
 
   Weight Loss Drug Market To Rocket To $130B By 2030 With Eli Lilly, Novo Nordisk In Lead: Goldman Sachs
   
  
  
  May 30, 2024
  From Benzinga
 From Benzinga
 
   Weight-Loss Drug Forecasts Skyrocket To $150B As Novo Nordisk, Eli Lilly Ramp Up Supply
   
  
  
  May 29, 2024
  From Benzinga
 
   A New Name in Weight Loss Drugs
   
  
  
  May 28, 2024
  From Motley Fool
 
   Novo Nordisk Faces Scrutiny Over High Prices of Ozempic And Wegovy, Blames US Health System
   
  
  
  May 28, 2024
  From Benzinga
 From InvestorPlace
 
   Ozempic Maker Novo Nordisk's Increasing Influence On Denmark's Employment Raises Economic Concerns
   
  
  
  May 28, 2024
  From Benzinga
 
   Soaring Eli Lilly Stock Could Climb Another 24% According to a Wall Street Analyst. Is the Stock a Buy Now?
   
  
  
  May 28, 2024
  From Motley Fool
 From InvestorPlace
 
   European Equities Close Higher As Traders Bank On Imminent ECB Rate Cut: What's Driving Markets Monday?
   
  
  
  May 27, 2024
  From Benzinga
 
   7 Biotech Stocks to Put on Your Breakthrough Radar
   
  
  
  May 27, 2024
  From InvestorPlace
 From Benzinga
 From Motley Fool
 
   3 High-Flying Stocks That Could Soar Even More
   
  
  
  May 25, 2024
  From Motley Fool
 From Benzinga
 
   Novo Nordisk Releases Data Showing Ozempic For Diabetes Slows Kidney Disease Progression
   
  
  
  May 24, 2024
  From Benzinga
 From InvestorPlace
 
   South Park Took On Crypto, AI Previously: Animated Comedy Targets Weight-Loss Drug Ozempic Next
   
  
  
  May 23, 2024
  From Benzinga
 From InvestorPlace
 
   Novo Nordisk's Once-Weekly Insulin Flagged With Risk Of Low Blood Sugar Ahead Of FDA Review
   
  
  
  May 22, 2024
  From Benzinga
 
   Australia Bans Replica Versions Of Popular Weight-Loss Drugs From Novo Nordisk, Eli Lilly On Safety Concerns
   
  
  
  May 22, 2024
  From Benzinga
 
   NeuroBo Pharmaceuticals Stock Slides Despite Animal Study Showing Wegvoy, Liver Fibrosis Success
   
  
  
  May 22, 2024
  From Benzinga
 
   This Biotech Stock Is Poised For 80% Upside With Breakthrough In Obesity Drug Market, Says JPMorgan
   
  
  
  May 21, 2024
  From Benzinga
 
   EXCLUSIVE: Roundhill Investments Launches Weight Loss ETF For Exposure To Blockbuster Drugs Like Ozempic
   
  
  
  May 21, 2024
  From Benzinga
 From InvestorPlace
 From Benzinga
 
   7 Reliable Blue-Chip Stocks That Cannot Miss
   
  
  
  May 21, 2024
  From InvestorPlace
 From Benzinga
 
   Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
  
  
 Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
  © 2025 FinancialContent. All rights reserved.
 

 
  
 
 
 










